A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting ...
This study tracked ultramarathon runners across 100 km, 160.9 km, and 230 km events to examine real-world metabolic, hormonal ...
Dr. Mario Acosta Mejía, CEO of Metabiogenix, has made history by receiving the RIKEN Health Impact Award and the prestigious title of Best Microbiome Scientist in Mexico for 2025, solidifying his ...